Alignment Healthcare (ALHC) – Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for Alignment Healthcare (NASDAQ: ALHC):

• 8/4/2026 – Alignment Healthcare had its “hold (c-)” rating reaffirmed by Weiss Ratings.
• 8/4/2026 – Alignment Healthcare had its price target lowered by JPMorgan Chase & Co. from $26.00 to $22.00. They now have an “overweight” rating on the stock.
• 8/3/2026 – Alignment Healthcare had its “buy” rating reaffirmed by TD Cowen.
• 8/3/2026 – Alignment Healthcare was downgraded by Raymond James Financial, Inc. from “strong-buy” to “outperform”. They now have a $19.00 price target on the stock, down from $22.00.
• 8/1/2026 – Alignment Healthcare was downgraded by Wall Street Zen from “buy” to “hold”.
• 7/8/2026 – Alignment Healthcare had its “neutral” rating reaffirmed by UBS Group AG.
• 7/6/2026 – Alignment Healthcare was downgraded by Zacks Research from “strong-buy” to “hold”.

Insiders Place Their Bets

In related news, insider Hyong Kim sold 35,951 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $19.86, for a total transaction of $713,986.86. Following the completion of the transaction, the insider directly owned 331,750 shares in the company, valued at $6,588,555. The trade was a 9.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Dawn Christine Maroney sold 30,000 shares of the business’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $19.55, for a total transaction of $586,500.00. Following the transaction, the president owned 947,313 shares of the company’s stock, valued at $18,519,969.15. This represents a 3.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 741,951 shares of company stock worth $14,943,747. Company insiders own 5.20% of the company’s stock.

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.